Obesity Organizations Release Consensus Statement
Six organizations that focus on the diagnosis and treatment of obesity have released a consensus statement to reduce barriers to care.
Six organizations that focus on the diagnosis and treatment of obesity have released a consensus statement to reduce barriers to care.
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.
Researchers delineate strategies to prevent weight gain and body composition changes among women during perimenopause and menopause.
Obesity and its related complications are a risk factor for adverse outcomes in people who contract COVID-19 infection. Investigators studied whether losing weight improved outcomes in people who lost weight after weight reduction surgery.
Researchers conducted an indirect treatment comparison of semaglutide 2.0 mg with dulaglutide 3.0 mg or 4.5 mg to observe which was superior in lowering HbA1c and body weight in people with type 2 diabetes.
Mango peel powder may decrease cholesterol, triglyceride, urea, and creatinine levels, and may help manage oxidative stress and dyslipidemia.
An experimental, injectable drug for type 2 diabetes may be superior to insulin for both glycemic and weight control.
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.